Tiangong University | China

Author Profile

🎓 Early Academic Pursuits

Dr. Yunlong Liu was born in August 1995 in Chengde, Hebei Province, China. His academic journey began with a strong foundation in the biological sciences, which led him to pursue a Ph.D. in Biochemistry and Molecular Biology at China Agricultural University from 2018 to 2023. During his doctoral studies, he delved into structural biology, focusing on unraveling the molecular mechanisms of transcriptional regulation mediated by nuclear receptors and other transcription factors. His exceptional research prowess and dedication earned him prestigious accolades, such as the National Ph.D. Scholarship and the Outstanding Doctoral Dissertation Award.

👨‍🏫 Professional Endeavors

Since August 2023, Dr. Liu has been serving as a Lecturer at the College of Life Sciences, Tiangong University. His transition from a promising Ph.D. scholar to a faculty member highlights his commitment to academia and scientific research. His role involves not only imparting knowledge to the next generation of scientists but also continuing his cutting-edge research in structural biology and transcriptional regulation.

🔬 Contributions and Research Focus

Dr. Liu's research is centered on understanding the structural and functional dynamics of nuclear receptors and transcription factors. He has determined seven crystal structures of protein monomers, protein-protein complexes, and protein-nucleic acid complexes. His work led to the identification of a nuclear receptor inhibitor with 100-fold enhanced efficacy, marking a significant breakthrough in molecular biology. His research contributions are reflected in his publications, including a sole first-author paper in Nucleic Acids Research with an impact factor of 19.16, as well as co-authored papers in Cell Discovery with an impact factor of 38.1 and the Journal of Biological Chemistry with an impact factor of 5.8. He has also played a crucial role in leading prestigious research projects, such as the National Natural Science Foundation of China and the Tianjin Top Scientist Studio Program, securing substantial funding for his research. His studies contribute to a deeper understanding of transcriptional regulation, a crucial aspect in fields like genetics, cancer research, and pharmaceutical development.

🏆 Accolades and Recognition

Dr. Liu’s remarkable contributions to structural biology have been acknowledged with numerous awards. He received the Outstanding Doctoral Dissertation Award and the Outstanding Ph.D. Graduate Award from China Agricultural University in 2023. In 2022, he was awarded the National Ph.D. Scholarship, ranking second in his college. During his undergraduate years, he secured the Second Prize in the National Mathematical Modeling Competition in 2016 and was a recipient of the National Inspirational Scholarships in 2016 and 2017. He was also honored as an Outstanding Graduate in 2018. These accolades highlight his exceptional academic excellence and research contributions.

🌍 Impact and Influence

Dr. Liu’s groundbreaking work has significantly influenced the field of structural biology, particularly in transcriptional regulation. His high-impact publications and research findings pave the way for advancements in drug discovery, genetic regulation, and medical therapeutics. By identifying novel molecular mechanisms and inhibitors, his work has the potential to drive innovations in treating diseases linked to transcriptional dysregulation, such as cancer and metabolic disorders. Beyond research, Dr. Liu's role as a lecturer enables him to inspire and mentor young scientists. His transition from a student to a faculty member positions him as a role model for aspiring biochemists and molecular biologists.

🚀 Legacy and Future Contributions

Looking ahead, Dr. Liu is set to make even more substantial contributions to the scientific community. His ongoing research projects, including those funded by national and provincial grants, will continue to advance the understanding of transcriptional regulation. With his expertise in structural biology and biochemistry, he is poised to make further discoveries that will shape the future of molecular medicine. As he continues his academic journey, Dr. Liu’s legacy will be defined by his unwavering dedication to science, his contributions to groundbreaking research, and his role in nurturing the next generation of scientists. His story is a testament to the power of perseverance, intellect, and scientific curiosity in pushing the boundaries of knowledge.

Publications

📄The Progress and Evolving Trends in Nucleic-Acid-Based Therapies
Authors: Yunlong Liu, Chunmiao Wang, Xiuping Fu, Mengtian Ren
Journal: Biomolecules
Year: 2025

📄Structural Basis of Nucleic Acid Recognition and 6mA Demethylation by Caenorhabditis elegans NMAD-1A
Authors: Guohui Shang, Meiting Yang, Min Li, Lulu Ma, Yunlong Liu, Jun Ma, Yiyun Chen, Xue Wang, Shilong Fan, Mengjia Xie, et al.
Journal: International Journal of Molecular Sciences
Year: 2024

📄Structures of Human TR4LBD–JAZF1 and TR4DBD–DNA Complexes Reveal the Molecular Basis of Transcriptional Regulation
Authors: Yunlong Liu, Lulu Ma, Min Li, Zizi Tian, Meiting Yang, Xi Wu, Xue Wang, Guohui Shang, Mengjia Xie, Yiyun Chen, et al.
Journal: Nucleic Acids Research
Year: 2023

📄Structures of MPND Reveal the Molecular Recognition of Nucleosomes
Authors: Meiting Yang, Xiaorong Li, Zizi Tian, Lulu Ma, Jun Ma, Yunlong Liu, Guohui Shang, Ailing Liang, Wei Wu, Zhongzhou Chen
Journal: International Journal of Molecular Sciences
Year: 2023

📄Structural Insights into the Interactions and Epigenetic Functions of Human Nucleic Acid Repair Protein ALKBH6
Authors: Lulu Ma, Hongyun Lu, Zizi Tian, Meiting Yang, Jun Ma, Guohui Shang, Yunlong Liu, Mengjia Xie, Guoguo Wang, Wei Wu, et al.
Journal: Journal of Biological Chemistry
Year: 2022

Pawan Gupta | Health Professions | Best Researcher Award

Posted on 20/12/202420/12/2024 by Book of Award

Dr. Pawan Gupta | Health Professions | Best Researcher Award

Innovative Cancer Care and Rehabilitation Pvt. Ltd | India

Author Profile

Scopus

Orcid

🌟 Early Academic Pursuits

Dr. Pawan Gupta’s academic journey reflects his passion for excellence in oncology and surgical practice. He graduated with an MBBS degree in 1991 from SCB Medical College, Cuttack, followed by an MS in General Surgery in 1996. In 2001, he completed his M.Ch. in Onco-Surgery at Gujarat University, further enhancing his skills with training at the Tata Memorial Hospital in Mumbai. His international exposure includes earning the FRCS I from the Royal College of Surgeons, Glasgow, and advanced training in voice rehabilitation and photodynamic therapy. These formative years laid the foundation for his groundbreaking career in cancer care.

🏥 Professional Endeavors

As the Senior Director of Head and Neck Cancer Surgery at MAX Institute of Cancer Care, Dr. Gupta has made significant strides in oncology. He is the visionary founder of ICanCaRe, a pioneering platform dedicated to cancer care and tobacco deaddiction. Through innovative tools like the ICanCaRe App, Virtual Clinics, and the National Quitline, his work has revolutionized patient rehabilitation. Additionally, his leadership roles include serving as National President and Senior Vice Chairman of the I CAN WIN Foundation, where he champions cancer prevention and treatment initiatives.

📚 Contributions and Research Focus

Dr. Gupta’s research and contributions are pivotal in advancing cancer care. With over 30 publications in esteemed journals and authorship of six influential books, he has enriched both the academic and practical fields of oncology. His patented instrument, TrisCaRe, demonstrates his commitment to innovation, addressing specific challenges in oral cancer treatment. As a master trainer for tobacco cessation under Gujarat University, Dr. Gupta has trained more than 1,000 specialists, cementing his role in global health initiatives.

🏅 Accolades and Recognition

Dr. Gupta’s impactful work has earned him numerous prestigious awards, including the ICD International Award (2007), the Vivekananda Sister Margarette Award (2017), and the Inspiring Oncologist 2024 Award by Times Network. These accolades honor his relentless dedication to cancer care, tobacco cessation, and public health advocacy.

🌍 Impact and Influence

Dr. Gupta’s influence extends far beyond clinical practice. His motivational talk, "Making of Cancer Winners," delivered at the Livestrong Global Summit in Dublin, inspired a global audience. His campaigns, such as "Win Over Cancer" and "Save the Youth – Win Over Tobacco," have garnered widespread recognition, transforming public attitudes toward cancer prevention and tobacco deaddiction.

🌱 Legacy and Future Contributions

Dr. Gupta’s holistic approach to oncology and his visionary projects, such as ICanCaRe, ensure his lasting legacy in the fight against cancer. As he continues to innovate and inspire, his work paves the way for a healthier, cancer-free future. His dedication to research, public education, and compassionate care underscores a career marked by transformative achievements and unwavering commitment to humanity.

Publications

📝 Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs
Authors: Kannan, S., Gokul Krishna, S., Gupta, P.K., Kolkundkar, U.K.
Journal: Scientific Reports
Year: 2024

📝 Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease
Authors: Gupta, P.K., Shivashankar, P., Rajkumar, M., Manjuprasad, M.S., Udaykumar, K.
Journal: Stem Cell Research and Therapy
Year: 2023

📝 Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
Authors: Gupta, P.K., Maheshwari, S., Cherian, J.J., Verma, N.N., Kumar, U.
Journal: American Journal of Sports Medicine
Year: 2023

📝 Comparison of guidelines for biological ancillary materials used for the manufacture of gene and cellular therapy products in Asia
Authors: Tanaka, T., Yoshimura, K., Chang, R., Zhao, X., Takakura, K.
Journal: Cytotherapy
Year: 2023

Hyun Min Kim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on 11/12/202411/12/2024 by Book of Award

Prof. Hyun Min Kim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Duke Kunshan University | China

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Prof. Hyun Min Kim's journey in the scientific realm began with a Bachelor of Science in Life Science from Hanyang University, Seoul, South Korea, in 1997. This foundational phase nurtured his interest in microbiology, leading to a Master of Science in Life Science (Microbiology) from the same institution in 1999. His academic ascent culminated in a Ph.D. in Applied Biology (Genetics and Molecular Cell Biology) at Georgia Institute of Technology, USA, in 2009, where he explored genome instability, tri-nucleotide repeats, and their genetic implications. This solid academic grounding propelled him toward groundbreaking discoveries.

👨‍🔬 Professional Endeavors

Prof. Kim’s illustrious career spans continents and decades, beginning as a Chief Research Scientist at Hanyang University Medical School, focusing on cytokine profiling and toll-like receptor proteins. His time as a Research Assistant and later a Post-doctoral Fellow at Harvard Medical School cemented his expertise in genome editing and DNA damage repair mechanisms.
His roles as Associate Professor at Tianjin University and Duke Kunshan University underscore his contributions to epigenetics and the development of CRISPR-Cas9 systems. Currently, he serves as an Associate Professor of the Practice at Duke University, advancing molecular biology through cutting-edge research on histone demethylases and DNA damage repair.

🔬 Contributions and Research Focus

Prof. Kim's research revolves around epigenetic regulation and genome editing. He has made pivotal contributions to understanding histone demethylases' roles in DNA damage repair and cancer pathways. His work on CRISPR-Cas9 has refined genome editing techniques, particularly in C. elegans, enabling advances in genetic and therapeutic research. His publications, spanning high-impact journals like Biomolecules, Frontiers in Genetics, and Nature Communications, highlight his dedication to elucidating molecular mechanisms influencing genetic stability and cancer development.

🏆 Accolades and Recognition

Prof. Kim's academic excellence has been consistently recognized. From early scholarships at Hanyang University to the prestigious Sarstedt® Graduate Student Award for his Ph.D. accomplishments, his journey is marked by accolades. He received the Faculty Teaching Award at Tianjin University and multiple travel and mentorship awards, showcasing his dual strengths as a researcher and educator. His innovative work has also attracted significant funding, including grants from the National Natural Science Foundation of China and the Kunshan Shuangchuang Grant, totaling millions in support for his transformative projects.

🌟 Impact and Influence

Prof. Kim's efforts have shaped the scientific and academic communities. His leadership roles, such as organizing journal clubs at Harvard Medical School and contributing to editorial boards like Life Journal and Jove Journal, underscore his influence. As a mentor, he has guided budding researchers and students, exemplified by his award for mentoring undergraduates at Georgia Tech. His findings in genome stability, CRISPR-Cas9, and epigenetics continue to inspire advancements in genetic engineering and cancer therapy.

✨ Legacy and Future Contributions

With an eye on the future, Prof. Kim remains committed to unraveling the mysteries of molecular genetics and epigenetics. His work lays a foundation for next-generation cancer therapeutics and genome editing platforms. As a leader in both teaching and research, his legacy will undoubtedly endure, fostering innovation and collaboration in life sciences globally.

Publications

📄 Torenia sp. Extracts Contain Multiple Potent Antitumor Compounds with Nematocidal Activity, Triggering an Activated DNA Damage Checkpoint and Defective Meiotic Progression

Author: Meng, Q., Borris, R.P., Kim, H.-M.
Journal: Pharmaceuticals
Year: 2024

📄 Exploring the Impact of Onobrychis cornuta and Veratrum lobelianum Extracts on C. elegans: Implications for MAPK Modulation, Germline Development, and Antitumor Properties

Author: Meng, Q., Pathak, N., Ren, X., Borris, R.P., Kim, H.-M.
Journal: Nutrients
Year: 2024

📖 LSD2 Is an Epigenetic Player in Multiple Types of Cancer and Beyond

Author: Kim, H.-M., Liu, Z.
Journal: Biomolecules
Year: 2024

📖 Experimental Insights into the Interplay between Histone Modifiers and p53 in Regulating Gene Expression

Author: Kim, H.-M., Zheng, X., Lee, E.
Journal: International Journal of Molecular Sciences,
Year: 2023

📖 A Decade of CRISPR-Cas Genome Editing in C. elegans

Author: Kim, H.-M., Hong, Y., Chen, J.
Journal: International Journal of Molecular Sciences
Year: 2022

Ridwan Salaam | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

Posted on 10/12/202410/12/2024 by Book of Award

Mr. Ridwan Salaam | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

University of Ibadan | Nigeria

Author Profile

Orcid

Google Scholar

🌟 Early Academic Pursuits

Ridwan Salaam’s academic journey reflects a deep commitment to scientific excellence. His Bachelor’s degree from Obafemi Awolowo University (OAU) laid the foundation for his expertise in molecular genetics, with a thesis focused on the chromosomal studies of Arvicanthis niloticus. He graduated with a Second Class Upper degree, achieving a remarkable GPA of 4.19/5.0. Building on this, he pursued a Master’s degree at the University of Ibadan, earning a distinction (GPA: 6.2/7.0). His thesis investigated the antiplasmodial activity of phytocompounds using in silico pharmacology, supervised by esteemed scholars like Dr. Afolayan Funmilayo I.D.

🚀 Professional Endeavors

With hands-on research experience spanning academia and industry, Ridwan has excelled in roles such as Research Intern at Hackbio, Graduate Research Assistant at the University of Ibadan, and Research Assistant at OAU. He has mastered advanced bioinformatics tools, molecular docking, and statistical analysis, actively contributing to cancer and infectious disease studies. His contributions extend to mentoring students, conducting DNA extractions, and organizing independent research groups like the Computer-Aided Biological Research Group (COMBReG).

🧬 Contributions and Research Focus

Ridwan’s research spans Cell Biology, Molecular Genetics, Drug Discovery, and Immunotherapy, with an emphasis on cancer and infectious diseases. He has published extensively on computational drug discovery, molecular docking, and network pharmacology. Notable works include elucidating antiplasmodial mechanisms and exploring phytocompounds for cancer treatments. He has participated in groundbreaking projects, such as developing multipotent antivenom under the 2023 TETFUND National Research Fund.

🏆 Accolades and Recognition

Ridwan’s achievements have garnered national and international recognition. His certificate of commendation from Government Secondary School, Maina, acknowledges his teaching contributions, while multiple workshop certifications highlight his expertise in computer-aided drug design and vaccine development. His collaborative research efforts have been showcased at prestigious conferences like the Zoological Society of Nigeria Annual Conference and the International Conference on Scientific Research in Nigeria.

🌍 Impact and Influence

As a convener of COMBReG and a research team coordinator, Ridwan has demonstrated exceptional leadership by fostering collaborative environments and driving innovation. He has trained over 40 participants in bioinformatics and spearheaded projects addressing global health challenges like malaria and cancer. His ability to work across diverse cultural and professional backgrounds has solidified his reputation as a team player and mentor.

📜 Legacy and Future Contributions

Ridwan Salaam’s robust academic background and research endeavors position him as a trailblazer in molecular genetics and bioinformatics. His work not only addresses pressing global health issues but also inspires future generations of scientists. With ongoing research in computational drug discovery and molecular pathways, Ridwan’s contributions are poised to leave a lasting impact on the fields of cancer therapy and infectious disease treatment. His journey exemplifies the spirit of innovation and dedication, promising a legacy of transformative research.

Publications

📄 A Review of Selected Parasitic Plants in Nigeria: Converting Harms to Benefits

Authors: Funmilayo I. D. Afolayan, Ridwan A. Salaam, Ebenezer S. Oladokun, Samson D. Adesoye
Journal: Natural Therapy Advances
Year: 2024

📄 Antiplasmodial Mechanism of Lawsonia inermis: An In Silico-Based Investigation

Authors: Ridwan Abiodun Salaam, Funmilayo I. D. Afolayan
Journal: Infectious Diseases Research
Year: 2024

📄 In Silico Discovery of Potential Androgen Receptor and Cytochrome P450 17A1 Inhibitors from Camellia sinensis for Prostate Cancer Treatment

Authors: Ridwan Abiodun Salaam, Christopher Terseer Tarkaa, Rachael Pius Ebuh, Damilare Adebayo Olaniyi, Sayo Ebenezer Oladokun, Rodiat Omotola Sowemimo, Oluwaponmile Florence Ajayi, Olusola Abayomi Akangbe
Journal: Next Research
Year: 2024

📄 In Silico and In Vivo Evaluations of Multistage Antiplasmodial Potency and Toxicity Profiling of n-Hexadecanoic Acid Derived from Vernonia amygdalina

Authors: Funmilayo I. D. Afolayan, R. A. Odeyemi, Ridwan A. Salaam
Journal: Frontiers in Pharmacology
Year: 2024

📄 Elucidating the Molecular Targets of Curcuma longa for Breast Cancer Treatment Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation

Authors: Christopher Terseer Tarkaa, Damilare Adebayo Oyaniyi, Ridwan Abiodun Salaam, Rachael Pius Ebuh, Olusola Abayomi Akangbe, Sayo Ebenezer Oladokun, Rodiat Omotola Sowemimo, Oluwaponmile Florence Ajayi
Journal: Precision Medicine Research
Year: 2023

Bin Zheng | Biomedicine | Best Researcher Award

Posted on 20/11/202420/11/2024 by Book of Award

Prof. Dr. Bin Zheng | Biomedicine | Best Researcher Award

Tianjin University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🌱

Prof. Dr. Bin Zheng’s academic journey began with a solid foundation in medical engineering and translational medicine. He further honed his expertise as a postdoctoral fellow at the Caroline School of Medicine, Sweden, laying the groundwork for a prolific career. His early pursuits in biomaterials and nanotechnology provided a strong base for his subsequent innovations and contributions to biomedical sciences.

Professional Endeavors 🏢

As a professor at Tianjin University's Academy of Medical Engineering and Translational Medicine, Dr. Zheng has led numerous research projects, including 10 completed and 6 ongoing endeavors. With over 30 impactful SCI publications, his work has gained recognition on a global scale. His collaborations with leading companies have fostered breakthroughs in cellular manufacturing and delivery technologies, enhancing both academic and industrial applications.

Contributions and Research Focus 🔬

Dr. Zheng’s work spans a wide range of fields, including biomaterials, cancer research, cellular microbiology, immunity, and nanobiotechnology. He has developed innovative therapeutic agents, including a nebulizable anti-bacterial spray targeting exosomes and stem cell extracts. His patents—70 published and 14 in progress—reflect his commitment to bridging the gap between laboratory research and clinical application.

Accolades and Recognition 🏆

Dr. Zheng’s outstanding contributions have earned him numerous awards, such as the Excellent Doctoral Dissertation of Tianjin Municipality and the First Prize for Innovative Achievements from the China Industry-University-Research Cooperation Association. Under his mentorship, graduate students have garnered over 20 prestigious awards, solidifying his role as an influential academic leader.

Impact and Influence 🌍

His research has been clinically translated and widely reported by media outlets like Science and Technology Daily and Science Net. As an editorial board member of prestigious journals, Dr. Zheng also influences the direction of global biomedical research. His international collaborations and contributions to standards like the Belt and Road LSEA 0006-2022 standard underscore his global impact.

Legacy and Future Contributions 🌟

Prof. Dr. Bin Zheng’s legacy lies in his innovative methodologies and translational focus, which continue to inspire the next generation of researchers. With ongoing projects in cutting-edge fields like optogenetics and cellular precision manufacturing, his future contributions are set to redefine the boundaries of medical engineering and translational medicine.

Publications

📄 Microorganism microneedle micro-engine depth drug delivery
Author(s): Zheng, B., Li, Q., Fang, L., Cheng, S.-X., Zhang, X.
Journal: Nature Communications
Year: 2024

📄 Near-infrared remote triggering of bio-enzyme activation to control intestinal colonization by orally administered microorganisms
Author(s): Sun, W., Yun, F., Guo, Q., Zheng, B., Ruan, X.
Journal: Acta Biomaterialia
Year: 2024

📄 Surface nanocoating-based universal platform for programmed delivery of microorganisms in complicated digestive tract
Author(s): Du, Y., Guo, H.L., Su, X., Wang, T., Zheng, B.
Journal: Journal of Colloid and Interface Science
Year: 2024

📄 A self-assembling bioactive oligopeptide hydrogel for the treatment of edema following prepuce surgery
Author(s): Liu, J., Pei, Y., Huang, Y., Chen, L., Zhou, Y.
Journal: Journal of Materials Chemistry B
Year: 2024

📄 NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain
Author(s): Han, H., Li, B., Yang, R., Bai, Y., Yu, Y.
Journal: ACS Biomaterials Science and Engineering
Year: 2024

Simeon Ikechukwu Egba | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

Posted on 11/11/202411/11/2024 by Book of Award

Dr. Simeon Ikechukwu Egba | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

Kampala International University | Uganda

Author Profile

Scopus

Orcid

Early Academic Pursuits 📚

Dr. Simeon Ikechukwu Egba’s academic journey began with his foundational education in Nigeria. After completing his secondary education at Community Secondary School, Eha-ohuala and Special Science School, Igbeagu, he pursued his undergraduate studies at the University of Nigeria, Nsukka, where he earned a Bachelor’s degree in Biochemistry in 2000. His academic curiosity and dedication to biochemistry led him to continue his studies at the same institution, earning a Master's degree in 2010 and later a Ph.D. in Biochemistry in 2014. His commitment to furthering his expertise in medical laboratory sciences was also demonstrated through studies at Nnamdi Azikiwe University Teaching Hospital-Nnewi.

Professional Endeavors 🏫

Dr. Egba's professional journey in academia spans over twelve years, during which he has held numerous positions that showcase his leadership and commitment to research and education. He has served as a lecturer in Biochemistry at various institutions, including Michael Okpara University of Agriculture, Umudike, and currently at Kampala International University, Uganda. His responsibilities have included teaching courses in biochemistry, overseeing laboratory sessions, and coordinating various academic functions such as the Student Industrial Work Experience Scheme (SIWES). Additionally, he has taken on key administrative roles, including being a member of the University Senate, and has led projects in research and curriculum development.

Contributions and Research Focus 🔬

Dr. Egba’s research interests are diverse and impactful, focusing on medical biochemistry, natural products, immune-modulation, endocrinology, and biochemical toxicology. His research has not only expanded the scientific understanding of these fields but has also contributed to real-world applications, such as exploring the immune-modulatory effects of herbal extracts and investigating glucose transport enhancement. He has made significant contributions to diabetes research, with several studies on anti-diabetic poly-herbal formulas. His scholarly work includes over 70 publications and successful supervision of 18 postgraduate students, many of whom have gone on to have successful academic careers.

Accolades and Recognition 🏅

Dr. Egba's academic excellence has earned him recognition within the scientific community. He has received multiple research grants, including those from the TETFUND, for projects that focus on diabetes and immunological responses. His dedication to his field is evident not only in his numerous publications but also in his role as a mentor, guiding over 150 undergraduate students through their research projects, many of whom have received scholarships to pursue postgraduate studies worldwide. Dr. Egba is an active member of the Nigerian Society of Biochemistry and Molecular Biology (NSBMB) and the Association of Medical Laboratory Scientists of Nigeria (AMLSN).

Impact and Influence 🌍

Dr. Egba’s impact extends beyond academia through his direct contributions to research and the development of future scholars. His research on the biochemical effects of natural products has influenced studies on immune-modulation and endocrinology, providing valuable insights into how natural compounds can influence human health. He has also played a pivotal role in improving the quality of laboratory practices and biochemistry education. His students, both undergraduate and postgraduate, continue to carry forward his legacy in research and academia, furthering his influence globally.

Legacy and Future Contributions 🌟

Dr. Egba’s future contributions are poised to further cement his legacy as a leading academic and researcher. His ongoing research projects aim to continue advancing the understanding of the biochemical pathways in diseases such as diabetes, and his work with poly-herbal formulations could have significant therapeutic implications. As he trains the next generation of biochemists and medical laboratory scientists, Dr. Egba’s influence will continue to shape the future of research and medical science, particularly in the fields of immunology and endocrinology.

Publication

📜 Effects of exposure to volatile organic compounds (VOCs) content from paint on automobile paint workers in Nsukka, South Eastern Nigeria
Authors: Ogbodo, J.O., Egba, S.I., Ogbodo, C.G., Onwurah, I.E., Njoku, O.U.
Journal: Heliyon
Year: 2024

📜 Understanding apoptosis in sickle cell anemia patients: Mechanisms and implications
Authors: Obeagu, E.I., Ubosi, N.I., Obeagu, G.U., Egba, S.I., Bluth, M.H.
Journal: Medicine (United States)
Year: 2024

📜 Evaluation of fertility hormones and biochemical stress initiated by toxicant in diet prepared with fish smoked with polyethylene (plastic) materials as a fuel source
Authors: Uhuo, E.N., Egba, S.I., Alaebo, P.O., Obike, C.A., Ede, I.S.
Journal: Comparative Clinical Pathology
Year: 2023

📜 Antioxidative properties of Adansonia digitata L. (baobab) leaf extract exert protective effect on doxorubicin-induced cardiac toxicity in Wistar rats
Authors: Uhuo, E.N., Egba, S.I., Nwuke, P.C., Obike, C.A., Kelechi, G.K.
Journal: Clinical Nutrition Open Science
Year: 2022

📜 Renoprotective effects of Adansonia digitata leaf extract on renal function and histopathological changes in vancomycin-induced nephrotoxicity in Wistar rats
Authors: Uhuo, E.N., Egba, S.I., Nwuke, P.N., Odinamadu, H.
Journal: Comparative Clinical Pathology
Year: 2022

Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Posted on 18/09/202418/09/2024 by Book of Award

Dr. Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Seoul National University College of Medicine | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Dong Hyun Kim embarked on his medical journey at the prestigious Seoul National University College of Medicine, earning his Bachelor of Medicine in 2019. His academic rigor continued with a Master's degree in Medical Science, specializing in Translational Medicine, which he completed in 2024. His academic training laid the foundation for his future endeavors in clinical oncology and hematologic malignancies, blending medicine with cutting-edge research.

Professional Endeavors 🏥

Dr. Kim's professional career began at Seoul National University Hospital, where he completed his internship and then advanced to a Resident Doctor position in the Department of Internal Medicine. His expertise expanded into the field of Hemato-Oncology, where he currently serves as an External Clinical Researcher. His clinical work, especially in the realm of cancer treatment and translational medicine, has contributed significantly to patient care and scientific discovery.

Contributions and Research Focus 🔬

Dr. Kim’s research has made a considerable impact on hematologic malignancies and the use of artificial intelligence in oncology. His work spans various domains, including allogeneic stem cell transplantation, tumor-infiltrating lymphocytes as biomarkers, and predictive modeling in cancer treatment. Through his numerous publications, he has explored innovative treatments and personalized medicine, particularly focusing on improving patient outcomes in myelofibrosis, thymic epithelial neoplasms, and head and neck squamous cell carcinoma.

Accolades and Recognition 🏅

Dr. Kim has received numerous awards that underscore his contributions to the field. He earned the Best Oral Presentation Award at ICBMT 2022, a Presidential Oral Presentation at JSMO 2024, and another Best Oral Presentation Award at ICKSH 2024. These recognitions reflect his leadership in oncology research and his ability to present complex ideas with clarity and authority.

Impact and Influence 🌍

Through his published works, Dr. Kim has influenced the global oncology community. His research on artificial intelligence in oncology, predictive biomarkers, and innovative therapeutic approaches has opened new pathways in cancer treatment. His contributions, especially in improving treatment strategies for hematologic malignancies and solid tumors, are helping shape the future of personalized medicine.

Legacy and Future Contributions 🌟

Dr. Kim is poised to continue influencing the fields of clinical oncology and translational medicine. His dedication to research, combined with his clinical expertise, ensures that he will remain a key figure in advancing cancer treatment and improving patient outcomes. His future endeavors, backed by a solid academic and professional foundation, are expected to further elevate the standards of oncological care and research.

Publications

📄 Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation
Author: Kim, D.H., Shin, D.-Y., Koh, Y., Byun, J.M., Hong, J.
Journal: Scientific Reports
Year: 2024

📄 Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea
Author: Kim, D.H., Youk, J., Byun, J.M., Yoo, S.H., Shin, D.-Y.
Journal: European Journal of Haematology
Year: 2024

📄 Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
Author: Kim, D.H., Lim, S.T., Kim, H.R., Shin, S.-H., Yun, H.J.
Journal: Oral Oncology
Year: 2024

📄 Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma
Author: Kim, D.H., Lim, Y., Ock, C.-Y., Kim, S.-B., Keam, B.
Journal: Head and Neck
Year: 2023

Livia Augustin | Medicine and Dentistry | Best Researcher Award

Posted on 05/08/202405/08/2024 by Book of Award

Dr. Livia Augustin | Medicine and Dentistry | Best Researcher Award

National Cancer Institute Pascale Napoli | Italy

Author Profile

Scopus

Early Academic Pursuits 🎓

Dr. Livia Augustin embarked on her academic journey with a Bachelor of Science in Nutritional Sciences and Human Biology from the University of Toronto in 1995, complemented by a minor in Psychology. Her passion for understanding the interplay between diet and health led her to pursue a Master of Science in Nutritional Sciences at the same institution, where she investigated the effects of wheat bran on serum lipids and colonic health. Dr. Augustin's quest for deeper knowledge culminated in a Doctor of Philosophy in Human Health and Nutritional Sciences from the University of Guelph in 2010. Her thesis explored the dietary glycemic index's implications on cancer risk, growth factors, and oxidative stress, marking a significant contribution to nutritional science.

Professional Endeavors 🌟

Dr. Augustin's professional career has been distinguished by her roles as a Nutrition Researcher and Study Coordinator at the National Cancer Institute Fondazione G. Pascale in Naples, Italy, since 2015. Her work has spanned across various esteemed institutions, including the Centro Riferimento Oncologico, Clinical Nutrition and Risk Factor Modification Centre at St. Michael’s Hospital, and the University of Milan. Her international collaborations extend to King's College London, Brighton University, and the Hellenic Health Foundation. Previously, she has worked at Unilever R&D, the Clinical Nutrition and Risk Factor Modification Centre, and as a Research Assistant at the Department of Epidemiology and the University of Toronto.

Contributions and Research Focus 🔬

Dr. Augustin's research has significantly advanced the understanding of lifestyle factors and their impact on cancer. Her notable studies include evaluating the long-term effects of integrated lifestyle treatments on breast cancer survivors and examining the influence of diet, exercise, and vitamin D supplementation on breast cancer recurrence. Her research has explored dietary habits, physical activity, and psychological states in breast cancer survivors, contributing valuable insights into improving quality of life and health outcomes in this population.

Accolades and Recognition 🏆

Dr. Augustin's contributions to nutritional science and cancer research have been recognized through several substantial grants. She has led projects funded by the Italian Ministry of Health and various Italian cancer research organizations, including LILT and the Lega Italiana per la Lotta contro i Tumori. Her grants support significant research into dietary interventions, cancer prevention, and quality of life improvements for cancer patients.

Impact and Influence 🌍

Dr. Augustin's work has had a profound impact on the field of nutrition and cancer research, influencing dietary recommendations and lifestyle interventions aimed at reducing cancer risk and improving patient outcomes. Her leadership in organizing scientific events and her role as a university speaker have further cemented her position as a leading figure in her field.

Legacy and Future Contributions 🌱

Looking ahead, Dr. Augustin continues to shape the future of nutritional science through her innovative research and commitment to improving cancer care. Her ongoing projects and collaborations promise to further advance our understanding of diet and lifestyle's role in health and disease. Her dedication to research supervision and student training also ensures that the next generation of scientists will benefit from her expertise and passion.

Publications 📘

📄Baseline Association between Healthy Eating Index-2015 and Health-Related Quality of Life in Breast Cancer Patients Enrolled in a Randomized Trial
Authors: Porciello, G., Coluccia, S., Vitale, S., Celentano, E., Augustin, L.S.A.
Journal: Cancers
Year: 2024

📄Diabetes Risk Reduction Diet and Colorectal Cancer Risk
Authors: Natale, A., Turati, F., Taborelli, M., Rossi, M., Vecchia, C.L.
Journal: Cancer Epidemiology Biomarkers and Prevention
Year: 2024

📄Central Obesity, Body Mass Index, Metabolic Syndrome and Mortality in Mediterranean Breast Cancer Patients
Authors: Crispo, A., Augustin, L.S.A., Luongo, A., La Vecchia, C., Arpino, G.
Journal: Scientific Reports
Year: 2023

📄Diabetes Risk Reduction Diet and Ovarian Cancer Risk: An Italian Case-Control Study
Authors: Esposito, G., Turati, F., Parazzini, F., Negri, E., La Vecchia, C.
Journal: Cancer Causes and Control
Year: 2023

📄One-Year Nutrition Counselling in the Context of a Mediterranean Diet Reduced the Dietary Inflammatory Index in Women with Breast Cancer: A Role for the Dietary Glycemic Index
Authors: Vitale, S., Palumbo, E., Polesel, J., Jenkins, D.J.A., Augustin, L.S.A.
Journal: Food and Function
Year: 2023

Feifei Feng | Health Professions | Best Researcher Award

Posted on 10/07/202411/07/2024 by Book of Award

Dr. Feifei Feng | Health Professions | Best Researcher Award

The Second Hospital of Shandong University | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Feifei Feng embarked on her academic journey in clinical medicine, obtaining a Master's degree through a seven-year program at Zhejiang University (2005-2012). She continued her education with a Doctor of Medicine (MD) degree in Internal Medicine from Qilu Medical College, Shandong University (2017-2020). Her academic training laid a robust foundation in both clinical and research aspects of internal medicine, particularly focusing on respiratory and critical care.

Professional Endeavors

Dr. Feng's professional career has been marked by her role as an Associate Chief Physician in the Department of Respiratory and Critical Care Medicine at the Second Hospital of Shandong University (09/2022 - Present). In this capacity, she is responsible for the daily consultation and treatment of patients with respiratory and critical care needs. Her work emphasizes the diagnosis and management of respiratory diseases, with a particular focus on lung cancer and pulmonary fibrosis.

Contributions and Research Focus

Dr. Feng's research has significantly contributed to understanding and treating respiratory diseases. Her research focus includes:

*Silicosis and Pulmonary Fibrosis: Dr. Feng has extensively studied the pathogenesis of silicosis and the therapeutic effects of compounds like Tanshinone IIA in attenuating silica-induced pulmonary fibrosis.

*Cancer Therapy: Her work on the inhibitory effects of polyphyllins and their role in enhancing chemosensitivity of cancer cells to treatments like cisplatin has been groundbreaking.

*Signaling Pathways: She has delved into the molecular mechanisms underlying disease processes, such as the TGF-β1/Smad signaling pathway, EMT, NOX4 inhibition, and Nrf2/ARE signaling activation.

Accolades and Recognition

Dr. Feng's contributions to the field have been widely recognized through numerous publications in high-impact journals. Some of her notable works include:

"Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA" (Biomed Pharmacother, 2024).

"Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling" (Chem Biol Interact, 2020).

Impact and Influence

Dr. Feng's research has had a profound impact on the medical community's understanding of respiratory diseases and their treatment. Her studies on the molecular pathways involved in pulmonary fibrosis and cancer therapy have opened new avenues for developing targeted treatments. By elucidating the mechanisms of disease and identifying potential therapeutic agents, her work has contributed to improved patient outcomes and advanced the field of respiratory medicine.

Legacy and Future Contributions

Dr. Feng continues to make strides in her field through her ongoing clinical practice and research. Her dedication to understanding complex respiratory diseases and finding innovative treatments ensures that her contributions will have a lasting impact. Future research endeavors are likely to build on her current work, exploring new therapeutic targets and improving the quality of care for patients with respiratory diseases. Her legacy will be marked by her commitment to advancing medical science and improving patient health outcomes.

Notable Publications

Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA 2024

Polyphyllin I induces apoptosis and autophagy in temozolomide-resistant glioma via modulation of NRF2 and MAPK-signaling activation 2023 (2)

Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway 2022 (8)

Detection and significance of exosomal mRNA expression profiles in the cerebrospinal fluid of patients with meningeal carcinomatosis 2021 (6)

Astragaloside IV alleviates silica‑induced pulmonary fibrosis via inactivation of the TGF‑β1/Smad2/3 signaling pathway 2021 (23)

Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on 23/04/202423/04/2024 by Book of Award

Mr. Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Hebrew University of Jerusalem | Israel

Author Profile

Orcid

Early Academic Pursuits

Mr. Jairus Nandwa's academic journey commenced with a Bachelor's in Industrial Microbiology and Biotechnology from The Technical University of Mombasa, Kenya. He pursued his passion further with a Master's in Biosciences from COMSATS University Islamabad, Pakistan, where he delved into cancer genetics. Currently, he is pursuing a Ph.D. in Genetics at The Hebrew University of Jerusalem, focusing on circular RNAs, SNORDs, and miRNAs in cancer under the guidance of Professor Ruth Sperling.

Professional Endeavors

Jairus has garnered diverse professional experiences, from his tenure as a Laboratory Analyst at the Regional Veterinary Investigation Laboratory, Kenya, to his role as the Head of Public Needs Research at the Integrated Cancer Research Foundation of Kenya. He has contributed significantly to cancer education and research, both as a volunteer and in leadership positions, demonstrating his commitment to advancing cancer management in Kenya.

Contributions and Research Focus

With a strong background in biochemistry, genetics, and molecular biology, Jairus has dedicated his research efforts to elucidating the roles of non-coding RNAs in gene expression regulation, tumor microenvironment, biomarker discovery, and DNA repair mechanisms. His research spans both experimental and computational domains, aiming to unravel the complexities of cancer genetics and improve therapeutic strategies.

Accolades and Recognition

Jairus's contributions to the field of cancer genetics have been recognized internationally. He has been awarded prestigious scholarships, including the Queen Elizabeth Commonwealth Scholarship, and has received honors for his academic achievements. Additionally, his research publications in reputable journals underscore his growing influence in the scientific community.

Impact and Influence

Through his research, leadership roles, and volunteer activities, Jairus has made a significant impact on cancer education, awareness, and research in Kenya. His work has contributed to the understanding of cancer pathogenesis and has paved the way for innovative approaches to cancer management and treatment.

Legacy and Future Contributions

As Jairus continues his doctoral studies and pursues his research interests in cancer genetics, he aims to leave a lasting legacy in the field through groundbreaking discoveries and transformative contributions. His multidisciplinary approach, coupled with his passion for scientific inquiry, positions him as a promising leader in cancer research with the potential to drive positive change in the global fight against cancer.

Notable Publications

Targeting allosteric sites on PDK-1 and PLK-1 with bioactive compounds from Daucus carota as a potential therapy for triple-negative breast cancer 2023